The pharmaceutical research and development facility serves as the new headquarters of Lexigen Pharmaceuticals, a subsidiary of Merck KGaA, Darmstadt, Germany. The site plan was designed to incorporate a final build-out of six buildings totaling 300,000 gross square feet: four R & D buildings, a Protein Production Laboratory, and a commercial manufacturing facility. Ellenzweig provided master planning, architectural design, laboratory planning and design, and construction administration services.
The Research and Development Building - one of the first facilities to be constructed in the multi-phased development - contains research laboratories, laboratory support areas, an animal facility, conference rooms, and administrative spaces. Research facilities include micro and biomedical laboratories, isotope laboratory, tissue culture rooms, darkrooms, and instrument rooms.
Workspaces are arranged around an enclosed atrium, designed to facilitate communication between the administrative and laboratory wings of the building. Laboratories feature limited interior partitions and in-lab corridors - open passages through the laboratory space needed for circulation and access but not for public egress. Used in this way, these corridors not only increase communication within the labs, but dramatically improve the net-to-gross ratio of the building. The new facility gives priority to daylight in the laboratories and offices and maximizes the views to the wooded countryside.